Wuying Cheng

448 total citations
38 papers, 307 citations indexed

About

Wuying Cheng is a scholar working on Surgery, Physiology and Oncology. According to data from OpenAlex, Wuying Cheng has authored 38 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Physiology and 9 papers in Oncology. Recurrent topics in Wuying Cheng's work include Neuroendocrine Tumor Research Advances (6 papers), Renal cell carcinoma treatment (5 papers) and Vascular Malformations and Hemangiomas (5 papers). Wuying Cheng is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Renal cell carcinoma treatment (5 papers) and Vascular Malformations and Hemangiomas (5 papers). Wuying Cheng collaborates with scholars based in China, United States and Norway. Wuying Cheng's co-authors include Guozhu Hou, Yuanyuan Jiang, Zhaohui Zhu, Yonghong Dang, Chenxi Wu, Li Huo, Fang Li, Fang Li, Xiaona Jin and Huijuan Zhu and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Wuying Cheng

36 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wuying Cheng China 10 97 96 76 64 62 38 307
Marie Meyer France 12 57 0.6× 49 0.5× 47 0.6× 88 1.4× 91 1.5× 29 319
Ferda Bilgir Türkiye 11 76 0.8× 31 0.3× 43 0.6× 49 0.8× 24 0.4× 34 338
Yukari Ichikawa Japan 12 79 0.8× 62 0.6× 174 2.3× 86 1.3× 279 4.5× 32 492
Ottavio Cavicchi Italy 12 87 0.9× 63 0.7× 27 0.4× 297 4.6× 56 0.9× 27 442
Yasuyuki Kamata Japan 11 45 0.5× 33 0.3× 81 1.1× 140 2.2× 63 1.0× 30 455
Hyewon Hyun United States 10 41 0.4× 27 0.3× 47 0.6× 61 1.0× 46 0.7× 24 278
Simin Schadmand‐Fischer Germany 11 35 0.4× 52 0.5× 77 1.0× 227 3.5× 73 1.2× 39 417
Thirachit Chotsampancharoen Thailand 13 33 0.3× 45 0.5× 36 0.5× 33 0.5× 47 0.8× 48 418
Giancarlo Candela Italy 10 40 0.4× 63 0.7× 36 0.5× 183 2.9× 44 0.7× 35 334
Masayuki Miyata Japan 12 45 0.5× 34 0.4× 134 1.8× 58 0.9× 183 3.0× 38 443

Countries citing papers authored by Wuying Cheng

Since Specialization
Citations

This map shows the geographic impact of Wuying Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuying Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuying Cheng more than expected).

Fields of papers citing papers by Wuying Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wuying Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuying Cheng. The network helps show where Wuying Cheng may publish in the future.

Co-authorship network of co-authors of Wuying Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wuying Cheng. A scholar is included among the top collaborators of Wuying Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wuying Cheng. Wuying Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Di, Jiao Li, Chenghui Lu, et al.. (2025). Reflective analysis on the current 131I adjuvant therapy indications in intermediate- and high-risk differentiated thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging. 52(9). 3125–3134. 1 indexed citations
2.
Ju, Gaoda, Hao Wang, Xin Zhang, et al.. (2023). Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 109(2). 505–515. 7 indexed citations
3.
Liu, Meixi, Peipei Wang, Li Huo, & Wuying Cheng. (2023). Hypermetabolic Broad Ligament Leiomyoma in Postmenopausal Women Mimicking Ovarian Tumors on 18F-FDG PET/CT. Clinical Nuclear Medicine. 48(4). 376–377.
4.
Hou, Guozhu, Yuanyuan Jiang, Wenshuai Xu, et al.. (2021). 68Ga-NOTA-Evans Blue PET/CT findings in lymphangioleiomyomatosis compared with 99mTC-ASC lymphoscintigraphy: a prospective study. Orphanet Journal of Rare Diseases. 16(1). 279–279. 2 indexed citations
5.
Hou, Guozhu, Yuanyuan Jiang, Zhaohui Zhu, et al.. (2021). Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma. Cancer Imaging. 21(1). 25–25. 12 indexed citations
6.
Jiang, Yuanyuan, Guozhu Hou, Fang Li, Zhaohui Zhu, & Wuying Cheng. (2021). Prognostic Value of FDG PET/CT in Patients With Neuroendocrine Carcinoma of the Uterine Cervix. Clinical Nuclear Medicine. 46(12). 971–976. 4 indexed citations
7.
Hou, Guozhu, Wenshuai Xu, Yuanyuan Jiang, et al.. (2020). Lymphangioleiomyomatosis revealed by 68Ga-NOTA-Evans Blue PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 47(10). 2469–2470. 3 indexed citations
8.
Jiang, Yuanyuan, et al.. (2020). FDG PET/CT Findings in a Patient With Ovarian Metastasis of Pheochromocytoma. Clinical Nuclear Medicine. 45(11). 931–932.
9.
Jiang, Yuanyuan, Guozhu Hou, Zhaohui Zhu, et al.. (2020). The value of multiparameter 18F-FDG PET/CT imaging in differentiating retroperitoneal paragangliomas from unicentric Castleman disease. Scientific Reports. 10(1). 12887–12887. 8 indexed citations
10.
Hou, Guozhu, Qingqing Pan, Ruixue Cui, Fang Li, & Wuying Cheng. (2020). Rosai-Dorfman Disease of the Right Atrium Revealed by FDG PET/CT. Clinical Nuclear Medicine. 45(9). 709–710. 2 indexed citations
11.
Jiang, Yuanyuan, Guozhu Hou, & Wuying Cheng. (2019). Renal Pelvis Involvement of Immunoglobulin G4–Related Disease Mimicking Malignancy on 18F-FDG PET/CT. Clinical Nuclear Medicine. 44(9). 767–768. 6 indexed citations
12.
Jiang, Yuanyuan, Guozhu Hou, & Wuying Cheng. (2019). Isolated involvement of thyroid gland by IgG4-related disease revealed by 18F-FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 47(3). 736–737. 2 indexed citations
13.
Hou, Guozhu, Yuanyuan Jiang, & Wuying Cheng. (2018). Ectopic corticotropin-releasing hormone syndrome caused by pancreatic neuroendocrine tumor localized by 68Ga-DOTATATE PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 46(3). 788–788. 5 indexed citations
14.
Hou, Guozhu, Xiaoqing Li, Bo Hou, Weixun Zhou, & Wuying Cheng. (2018). Lymphangioma on 68Ga-NOTA-Evans Blue PET/MRI. Clinical Nuclear Medicine. 43(7). 553–555. 5 indexed citations
15.
Wu, Chenxi, Wuying Cheng, Yi Sun, et al.. (2014). Activating Brown Adipose Tissue for Weight Loss and Lowering of Blood Glucose Levels: A MicroPET Study Using Obese and Diabetic Model Mice. PLoS ONE. 9(12). e113742–e113742. 32 indexed citations
16.
Cheng, Wuying, et al.. (2012). Intense FDG Activity in the Brown Adipose Tissue in Omental and Mesenteric Regions in a Patient With Malignant Pheochromocytoma. Clinical Nuclear Medicine. 37(5). 514–515. 24 indexed citations
17.
Zhu, Zhaohui, et al.. (2010). FDG PET/CT Detection of Intussusception Caused by Aggressive Fibromatosis. Clinical Nuclear Medicine. 35(5). 370–373. 7 indexed citations
18.
Cheng, Wuying, et al.. (2010). Hepatic Paragonimiasis Revealed by FDG PET/CT. Clinical Nuclear Medicine. 35(9). 726–728. 17 indexed citations
19.
Zhu, Zhaohui, et al.. (2007). [Characteristics of physiological uptake of uterus and ovaries on 18F-fluorodeoxyglucose positron emission tomography].. PubMed. 29(1). 124–9. 4 indexed citations
20.
Zhu, Zhaohui, Bocheng Wang, Wuying Cheng, et al.. (2006). Endometrial and Ovarian F-18 FDG Uptake in Serial PET Studies and the Value of Delayed Imaging for Differentiation. Clinical Nuclear Medicine. 31(12). 781–787. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Meyer Breakdown of academic impact, for papers by Ferda Bilgir Breakdown of academic impact, for papers by Yukari Ichikawa Breakdown of academic impact, for papers by Ottavio Cavicchi Breakdown of academic impact, for papers by Yasuyuki Kamata Breakdown of academic impact, for papers by Hyewon Hyun Breakdown of academic impact, for papers by Simin Schadmand‐Fischer Breakdown of academic impact, for papers by Thirachit Chotsampancharoen Breakdown of academic impact, for papers by Giancarlo Candela Breakdown of academic impact, for papers by Masayuki Miyata
Rankless by CCL
2026